ITGB3 and neoplasm: In a recent study, Kmt2c−/− mammary outgrowths from organoids showed enrichment in stem-cell-basal markers (CD49hi, CD61+) and activation of the PI3K pathway [101], an observation we did not see in our mouse tumours.